FindTrial
Sign In

Efficacy of SGLT2I and TZD hypoglycemic drugs in patients with type 2 diabetes mellitus

Efficacy of SGLT2I and TZD hypoglycemic drugs in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051175
Enrollment
Unknown
Registered
2021-09-15
Start date
2021-09-30
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

SGLT2I+TZD group:Nil
SGLT2I+DPP4I group:Nil
DPP4I+TZD group:Nil

Sponsors

Tianjin Fourth Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus; 18 ~ 70 years old; Patients who use oral drugs to control blood glucose.

Exclusion criteria

Exclusion criteria: 1. Gestational diabetes or diabetes complicated by pregnancy; 2. Combined with stroke or serious mental illness, unconsciousness; 3. Patients with active pulmonary tuberculosis and other infectious diseases; 4. Patients with severe heart and lung function and liver and kidney insufficiency.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin;weight;—

Countries

China

Contacts

Public ContactShao Hailin

Tianjin Fourth Central Hospital

shaohailin1988@sohu.com+86 22 26249403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026